Blood & Cancer
By Medscape Professional Network
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Medscape Professional Network
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 10
Reviews: 0
Episodes: 100
Description
The official podcast feed of MDedge Hematology-Oncology, part of the Medscape Professional Network. On Thursdays, Dr. David Henry interviews key opinion leaders and rising stars in hematology and oncology. The information in this podcast is provided for informational and educational purposes only.
| Episode | Date |
|---|---|
|
Biosimilars with Dr. Gary Lyman
|
May 27, 2021 |
|
Advanced bladder cancer: Dr. Arjun Balar talks treatment strategies in a changing field
|
May 20, 2021 |
|
Gene therapies in hemophilia with Dr. Glenn Pierce
|
May 13, 2021 |
|
Thrombosis and thrombocytopenia caused by COVID-19 vaccines: How to identify and treat VITT, VIPIT, or TTS
|
May 06, 2021 |
|
Toward more personalized treatment in prostate cancer: The CCR score predicts metastasis and guides treatment decisions after radiation
|
Apr 29, 2021 |
|
Changing perspectives: Dr. Michael Weiner recounts his experiences as an oncologist who became a cancer patient and then a caregiver
|
Apr 22, 2021 |
|
Optimizing CAR T-cell therapies in lymphoma: Improving response, fighting cytokine release syndrome, and identifying mechanisms of resistance
|
Apr 15, 2021 |
|
Trends in genetic testing for breast and ovarian cancer: Undertesting and racial/ethnic disparities persist
|
Apr 08, 2021 |
|
Improving cancer screening in the COVID era: Drive By Flu-FIT allows for socially distanced colorectal cancer screening
|
Apr 01, 2021 |
|
Unpacking von Willebrand disease guidelines: Dr. Paula James talks diagnosis and pre-procedure prophylaxis
|
Mar 25, 2021 |
|
FDA approvals in hematology and oncology, Part II: New oral formulations, RET and MET inhibitors, and CAR T-cell therapies
|
Mar 18, 2021 |
|
How I treat CLL and MCL: From ‘watch and wait’ to BCL2 and BTK inhibitors, CAR T-cell therapy, and transplant
|
Mar 11, 2021 |
|
COVID-19 vaccination in cancer patients: Who should be vaccinated and when?
|
Mar 04, 2021 |
|
Managing pain in sickle cell crisis with Dr. Ifeyinwa Osunkwo
|
Feb 25, 2021 |
|
FDA approvals in hematology and oncology: Novel agents and new tricks for old drugs
|
Feb 18, 2021 |
|
NCI-MATCH trial reveals actionable mutations and matches cancer patients to targeted therapies
|
Feb 11, 2021 |
|
COVID-19 vaccine 101: Dr. Drew Weissman discusses mechanisms, efficacy, and vaccinating patients with cancer or HIV
|
Feb 04, 2021 |
|
Barriers to clinical trial enrollment for patients with gynecologic cancers: Why patients don’t participate and how to improve enrollment
|
Jan 28, 2021 |
|
Convalescent plasma for COVID-19, race linked to cancer-associated thrombosis risk, iron deficiency common in pregnancy, and more from ‘Best of ASH’
|
Jan 21, 2021 |
|
Thrombosis research from ASH 2020: Khorana score falls short in cancer study, factors predict VTE in cancer patients with COVID-19, and antithrombotics don’t affect severe COVID outcomes
|
Jan 14, 2021 |
|
Highlights from SABCS 2020: New data on CDK4/6 inhibitors, omitting chemotherapy and radiotherapy, underreporting toxicity, and predicting outcomes in breast cancer
|
Jan 07, 2021 |
|
Best of Blood & Cancer 2020
|
Dec 24, 2020 |
|
SABCS 2020: More women may forgo chemo, surgery's role in opioid use, and pregnancy after breast cancer
|
Dec 22, 2020 |
|
How does COVID-19 affect patients with hematologic malignancies? The ASH registry provides some answers
|
Dec 17, 2020 |
|
News from ASH 2020: 'Practice-changing' results with ruxolitinib in chronic GVHD and no benefit seen with tranexamic acid in patients with blood cancers and severe thrombocytopenia
|
Dec 15, 2020 |
|
How I treat GVHD: Dr. James Ferrara explains how biomarkers can predict outcomes and guide the treatment of acute GVHD
|
Dec 10, 2020 |
|
Black patients with ES-SCLC get less chemo, CTCs may guide breast cancer treatment, and new FDA approvals for neuroblastoma and prostate cancer
|
Dec 08, 2020 |
|
Can aerosolized chemotherapy better treat peritoneal carcinomatosis in patients with gynecologic or gastrointestinal cancers?
|
Dec 03, 2020 |
|
News | Checkpoint inhibitors and COVID-19 mortality; HCC rates slow in cities, continue to climb in rural areas
|
Dec 01, 2020 |
|
Journal highlights with Dr. David Henry: Managing hematologic conditions in pregnancy, combo for elderly AML, genomics in DLBCL, and COVID-19 updates
|
Nov 26, 2020 |
|
Cancer and hepatitis B virus: ASCO's recommendations for HBV screening, monitoring for reactivation, and how to treat patients
|
Nov 19, 2020 |
|
How to kill a trial
|
Nov 17, 2020 |
|
Post-HSCT care at home: Can maintaining the patient’s microbiome prevent GVHD, improve other outcomes, decrease costs, and reduce the risk of COVID-19?
|
Nov 12, 2020 |
|
Real-world checkpoint inhibitor results not as good as trial results
|
Nov 10, 2020 |
|
How I treat NSCLC in the era of checkpoint inhibitors and the COVID-19 pandemic
|
Nov 05, 2020 |
|
Breast cancer risk with HRT, statins and colorectal cancer, and SBRT for lung metastases
|
Nov 03, 2020 |
|
How to use antiemetics: Dr. Paul Hesketh reviews ASCO’s guidelines on antiemetic use in cancer patients receiving checkpoint inhibitors or antineoplastic agents
|
Oct 29, 2020 |
|
Patients will gain access to clinical notes, lung cancer screening guidelines fall short, and AML standard remains elusive
|
Oct 27, 2020 |
|
Hematology case review: Suspected ITP, presumed heparin-induced thrombocytopenia, and an ‘interesting’ case of anemia
|
Oct 22, 2020 |
|
Choosing surgery for older breast cancer patients, delayed screening from COVID-19 could increase deaths, and blood group O linked to decreased SARS-CoV-2 risk
|
Oct 20, 2020 |
|
TERAVOLT registry sheds light on characteristics, treatment, and outcomes of patients with thoracic cancers and COVID-19
|
Oct 15, 2020 |
|
FDA approves combo immunotherapy for mesothelioma, atezolizumab strikes out in ovarian cancer, and more
|
Oct 13, 2020 |
|
The psychiatry of cancer, a crossover from the Psychcast
|
Oct 08, 2020 |
|
Global stomach cancer deaths decline but colorectal cancer deaths stagnate; plus, divergent results for paclitaxel/nab-paclitaxel for triple negative breast cancer
|
Oct 06, 2020 |
|
ESMO 2020: Late-breaking and practice-changing studies on COVID-19 and breast, lung, gastrointestinal, and other cancers
|
Oct 01, 2020 |
|
Hem-Onc News: No benefit from postop radiotherapy in NSCLC, sotorasib is a 'triumph of drug discovery,' and choosing a TKI for ALL
|
Sep 29, 2020 |
|
Studying cancer patients with COVID-19: Dr. Brian Rini describes the NCCAPS and CCC19 studies and reviews the latest findings
|
Sep 24, 2020 |
|
Waist size and prostate cancer death, AI is on par with radiologists for mammograms, and "How I Treat" MDS from ASH Hematologic Malignancies
|
Sep 22, 2020 |
|
Medical school in the COVID era: Two RCSI students explain how the pandemic has affected them
|
Sep 17, 2020 |
|
Gene testing for all breast cancer patients with second primary malignancy, atezolizumab for TNBC, pralsetinib for NSCLC, and more
|
Sep 15, 2020 |
|
How I treat MDS: Dr. Shannon McCurdy talks prognostic scoring, ESAs, HMAs, transplant, and more
|
Sep 10, 2020 |
|
Hem-Onc News: Delaying radiotherapy for high-risk prostate cancer; melanoma experts say 'no' to routine gene profile testing
|
Sep 08, 2020 |
|
Best of the 2020 American Society of Clinical Oncology Annual Meeting
|
Sep 03, 2020 |
|
Hem-Onc News: Aspirin linked to cancer progression in older adults, inhibitor could 'alter landscape' of RET+ tumors, and Black-White gap closing
|
Sep 01, 2020 |
|
SECURE-SCD: A registry of patients with sickle cell disease and COVID-19
|
Aug 27, 2020 |
|
Diabetes + weight loss could mean a higher risk of pancreatic cancer, digital breast tomosynthesis vs digital mammography, and adjuvant chemo is beneficial for some with low-grade glioma
|
Aug 25, 2020 |
|
Mason Plumlee: NBA star in the Orlando bubble, medical entrepreneur, and COVID-19 survivor
|
Aug 20, 2020 |
|
Hem Onc News: Chemo-free treatment of mesothelioma, FDA approves liquid biopsy for NSCLC, and swallowable device for esophageal cancer
|
Aug 18, 2020 |
|
ISTH 2020: Dr. Hanny Al-Samkari talks VTE in COVID-19, bevacizumab in HHT, and predisposition to thrombosis in NSCLC
|
Aug 13, 2020 |
|
Immunotherapy doesn't impact COVID mortality, breast cancer screening for the developing world, and 2 FDA approvals
|
Aug 11, 2020 |
|
How I treat multiple myeloma: Dr. Gustavo Fonseca talks triple-agent therapy, transplant, and treatment failure
|
Aug 06, 2020 |
|
News from EAU20, ISTH, and AACR's COVID-19 & Cancer meeting: Surgery in renal cell cancer, bevacizumab in HHT, and nosocomial COVID-19
|
Aug 04, 2020 |
|
Beyond the lungs: How COVID-19 affects the blood, brain, gastrointestinal system, and other organ systems
|
Jul 30, 2020 |
|
RTL 03 - HemOnc News: New 'gold standard' for prostate cancer screening, pandemic could increase cancer deaths, genetic testing for early cancers
|
Jul 28, 2020 |
|
Hematology|Oncology Journal Club 01 - All about breast cancer: Lumpectomy margins, partial vs whole breast irradiation, locoregional management after neoadjuvant chemo
|
Jul 23, 2020 |
|
RTL 02 -- The latest news from MDedge Hematology/Oncology: MRI IDs significant prostate cancer, drug interactions to avoid in GI cancers, ctDNA clearance tracks with NSCLC survival, COVID symptoms persist
|
Jul 21, 2020 |
|
Cancer and diet: Dr. Dawn Lemanne describes how fasting can suppress the immune system and lower IGF-1 and blood sugar levels
|
Jul 16, 2020 |
|
Introducing Run the List: the latest hem onc news - Earlier lung screening doubles eligibility, lifestyle reduces breast cancer risk regardless of genetics, FDA approves MDS/CMML drug, COVID mask exemptions
|
Jul 14, 2020 |
|
Personal and professional impact of COVID-19 - diary of an oncologist and vacation on the shore
|
Jul 09, 2020 |
|
Patient anxiety, social support, optimism bias, and 'How long do I have left?': The best-of Dr. Ilana Yurkiewicz
|
Jul 02, 2020 |
|
EHA25: AML, myeloma, polycythemia vera, and COVID-19 with EHA President John Gribben
|
Jun 25, 2020 |
|
Drugs FDA-approved for hematology / oncology in 2020: ‘Game-changing’ and ‘niche’ indications
|
Jun 18, 2020 |
|
ASCO 2020: Practice-changing studies in breast, lung, colorectal, and other cancers
|
Jun 11, 2020 |
|
Non–small cell lung cancer: How to choose the best therapy and reviewing the first virtual ASCO
|
Jun 04, 2020 |
|
Would you choose oncology again? Plus, breast cancer research: HER2CLIMB, KEYNOTE 522, and DESTINY BREAST01 with Dr. Bill Gradishar
|
May 28, 2020 |
|
VTE rate, 'COVID toes,' and Virchow's triad: What you need to know about COVID and coagulation
|
May 21, 2020 |
|
Curbsiders Host Dr. Matt Watto on being an internist in the COVID-19 pandemic
|
May 14, 2020 |
|
Treating genitourinary malignancies in the COVID-19 era
|
May 07, 2020 |
|
The first virtual ASCO meeting; plus Part 2 of tech tools for docs
|
Apr 30, 2020 |
|
Treating colorectal cancer in the COVID-19 era
|
Apr 23, 2020 |
|
COVID-19 and the community oncologist
|
Apr 16, 2020 |
|
COVID-19 and lung cancer: The decision to delay treatment
|
Apr 09, 2020 |
|
Bonus: COVID-19 critical-care lessons from Seattle
|
Apr 07, 2020 |
|
COVID-19: ‘The world has changed’
|
Apr 02, 2020 |
|
Grands rounds in the age of COVID-19; cardiotoxicity in breast cancer
|
Mar 26, 2020 |
|
Tech tools for docs: Apps, sites, and software in the virtual world
|
Mar 19, 2020 |
|
Common bleeding and coagulation issues
|
Mar 12, 2020 |
|
Is this a good study? The statistics tell the story
|
Mar 05, 2020 |
|
Treatment approaches in AML
|
Feb 27, 2020 |
|
Treatment tips in CLL
|
Feb 20, 2020 |
|
When to refer for CAR T-cell therapy
|
Feb 13, 2020 |
|
Understanding biosimilars
|
Feb 06, 2020 |
|
ASH19 special report
|
Jan 30, 2020 |
|
Sickle cell update: Treating pain and progress toward cure
|
Jan 23, 2020 |
|
Practice-changing research in GI cancer
|
Jan 16, 2020 |
|
Palliative care: Not just another word for hospice
|
Jan 09, 2020 |
|
The best of Clinical Correlation
|
Jan 02, 2020 |
|
ICYMI: Get to know Dr. Ilana Yurkiewicz
|
Dec 26, 2019 |
|
ASCO president on uniting the oncology field
|
Dec 19, 2019 |
|
2019 drug approvals in hematology-oncology
|
Dec 12, 2019 |